Management of Patients with Advanced Non-Small Cell Lung Cancer: Current and Emerging Options

Author： Triano Laura R.   Deshpande Hari   Gettinger Scott N.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.2, 2010-01, pp. : 167-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for non-small cell lung cancer

By Cappuzzo Federico   Bartolini Stefania   Crinò Lucio  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 179-192

Informa Healthcare

Access to resources Recommend Favorite

The role of gefitinib in the management of Asian patients with non-small cell lung cancer

By Chang Alex Y  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 401-411

Informa Healthcare

Access to resources Recommend Favorite

Taxanes for advanced non-small cell lung cancer

By Ramalingam Sakkaraiappan   Belani Chandra P  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1693-1709

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed in advanced non-small cell lung cancer

By Gridelli Cesare   Maione Paolo   Rossi Antonio   Bareschino Maria Anna   Schettino Clorinda   Sacco Paola Claudia   Zeppa Rosario  

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite

ALK-positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options

By Steuer Conor E.   Ramalingam Suresh S.  

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2392-2402

Blackwell Publishing

Access to resources Recommend Favorite